Baxter International Inc Completes Acquisition Of Gambro AB And Enhances Global Leadership In Renal Therapies

Friday, 6 Sep 2013 07:00am EDT 

Baxter International Inc announced that the Company has completed the acquisition of Gambro AB, a privately held global medical technology company and dialysis products based in Lund, Sweden. The transaction further enhances Baxter's global renal leadership and provides the Company with a comprehensive product and therapies portfolio to meet the needs of patients in the and growing dialysis market. The total cash consideration for the transaction was approximately $3.9 billion USD. The transaction was financed through a combination of cash generated from overseas operations and debt issuances. 

Company Quote

1.09 +1.51%
10:18am EST